Esperion Therapeutics, Inc. (ESPR)
Esperion Therapeutics, Inc. (ESPR)
$36.56 USD
Updated Sep 13 12:00am
Add ESPR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
ESPR Stock Chart More Charts
ESPR Price/Volume Stats
| Current price | $36.56 |
| Prev. close | $36.74 |
| Day low | $36.52 |
| Day high | $38.17 |
| 50-day MA | $39.80 |
| 200-day MA | $44.72 |
| 52-week high | $60.99 |
| 52-week low | $33.13 |
| Volume | 309,300 |
| Avg. volume | 536,451 |
| Dividend yield | N/A |
| Market Cap | 993.37M |
Esperion Therapeutics, Inc. (ESPR) Company Bio
Esperion Therapeutics is focused on developing and commercializing first-in-class, oral, LDL-cholesterol-lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. The company was founded in 1998 and is based in Ann Arbor, Michigan.
Top Stories View All
101 Fresh Upgrades to Start the Week
2900 or 3100: Which Comes Next?
Best & Worst Performing Stock Industries for September 13, 2019
Best & Worst Performing Small Cap Stocks for September 13, 2019
Best & Worst Performing Large Cap Stocks for September 13, 2019
View All Top Stories
Loading social stream, please wait...